Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Hydrocortisone vs Ondansetron for Post-Spinal Hypotension
NCT06930456Enrolling by invitation
- Start
- Mar 2024
- Primary completion
- Mar 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, double-blind trial of hydrocortisone and ondansetron in hypotension (3 arms). Primary endpoint: Incidence of Hypotension at 30 minutes. Started Mar 2024; status: enrolling by invitation.
02
Drugs
hydrocortisoneondansetron
03
Conditions
hypotension
Beyond the preview
Go deeper on NCT06930456.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06930456.